Innovative Peptide Manufacturing Methods That Scale

Joseph Denby

SR. MANAGER OF BUSINESS DEVELOPMENT – EU
CPC SCIENTIFIC INC.

Joseph Denby

SR. MANAGER OF BUSINESS DEVELOPMENT – EU

Presentation at NextGen Biomed 2026

Key Highlights

  • Rising peptide demand, fueled by strong GLP-1 momentum, is driving the need for scalable production that supports commercial timelines
  • Solid-phase peptide synthesis (SPPS) is essential, yet its waste intensity makes process efficiency and sustainability a key focus for CDMOs
  • CPC Scientific’s Case Study: Our SPPS process innovations supported multi-kilo delivery of a pharmaceutically relevant polypeptide while reducing cost, environmental impact, and time to market

Timestamps

  • 4:52 – Peptide Market Growth & Manufacturing Evolution
  • 8:01 – CDMO Priorities & Case Study Overview
  • 9:49 – Key Process Innovations
  • 15:45 – Closing Insights

Interested in optimizing your SPPS process at scale?

Connect with our team to explore how strategic process design can enhance sustainability and delivery timelines for your peptide and oligo programs.

Biography

Joseph Denby is the Senior Manager of Business Development for CPC Scientific. He has a background in biochemistry and nearly a decade of experience in the commercial sector. His role is to support CPC Scientific’s clients in advancing their peptide and oligonucleotide NCEs from discovery through to commercialization — with a focus on prioritizing expertise and communication to enable productive, long-lasting collaborations.